Sponsor
Novo Nordisk A/S
Clinical research sponsor
Clinical trials
60 shownA Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to SemaglutideNCT07668414 · lead sponsor · 2026-09-22
RECRUITINGResearch Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to CagrisemaNCT07817251 · lead sponsor · 2026-09-16
RECRUITINGAMAZE 10: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People in Japan With Excess Body Weight Lose WeightNCT07822061 · lead sponsor · 2026-09-07
RECRUITINGA Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or ObesityNCT07815067 · lead sponsor · 2026-09-07
RECRUITINGAMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose WeightNCT07720271 · lead sponsor · 2026-08-31
RECRUITINGAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsNCT07797335 · lead sponsor · 2026-08-24
RECRUITINGA First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or ObesityNCT07767175 · lead sponsor · 2026-08-12
RECRUITINGResearch Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body WeightNCT07770841 · lead sponsor · 2026-08-12
RECRUITINGA Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesNCT07282613 · lead sponsor · 2026-08-04
RECRUITINGA Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body WeightNCT07745504 · lead sponsor · 2026-08-04
RECRUITINGA Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity, Compared to a Low-calorie Diet or PlaceboNCT07757087 · lead sponsor · 2026-08-03
RECRUITINGA Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become PregnantNCT07710729 · lead sponsor · 2026-07-17
RECRUITINGA Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body WeightNCT07710768 · lead sponsor · 2026-07-15
RECRUITINGA Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With ObesityNCT07693868 · lead sponsor · 2026-07-06
RECRUITINGA Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 DiabetesNCT07668388 · lead sponsor · 2026-06-22
RECRUITINGA Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy ParticipantsNCT07656454 · lead sponsor · 2026-06-17
RECRUITINGEvaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse EventsNCT07607587 · lead sponsor · 2026-05-29
RECRUITINGA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightNCT07564414 · lead sponsor · 2026-05-21
RECRUITINGA Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or ObesityNCT07597018 · lead sponsor · 2026-05-18
RECRUITINGA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityNCT07567001 · lead sponsor · 2026-05-11
RECRUITINGA Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or ObesityNCT07578584 · lead sponsor · 2026-05-07
RECRUITINGAMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNCT07571109 · lead sponsor · 2026-05-05
RECRUITINGAMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNCT07571005 · lead sponsor · 2026-05-05
RECRUITINGA Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DMNCT07570992 · lead sponsor · 2026-05-04
RECRUITINGA Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or ObesityNCT07566390 · lead sponsor · 2026-05-01
RECRUITINGA Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or ObesityNCT07557953 · lead sponsor · 2026-04-30
RECRUITINGAMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainNCT07509307 · lead sponsor · 2026-04-20
RECRUITINGA Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 DiabetesNCT07415954 · lead sponsor · 2026-04-17
RECRUITINGAMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightNCT07533175 · lead sponsor · 2026-04-13
RECRUITINGA Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainNCT07481630 · lead sponsor · 2026-04-13
RECRUITINGUnderstanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)NCT07527195 · lead sponsor · 2026-04-10
RECRUITINGInvestigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 DiabetesNCT07535307 · lead sponsor · 2026-04-10
RECRUITINGA Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With ObesityNCT07508020 · lead sponsor · 2026-03-30
RECRUITINGA Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) ParticipantsNCT07532863 · lead sponsor · 2026-03-13
RECRUITINGA Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or ObesityNCT07437079 · lead sponsor · 2026-02-24
RECRUITINGAMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose WeightNCT07339423 · lead sponsor · 2026-02-24
RECRUITINGA Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or ObeseNCT07411560 · lead sponsor · 2026-02-09
RECRUITINGA Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or ObesityNCT07395687 · lead sponsor · 2026-02-02
RECRUITINGA Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightNCT07253285 · lead sponsor · 2026-01-08
RECRUITINGA Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 DiabetesNCT07270731 · lead sponsor · 2025-11-25
RECRUITINGExamination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)NCT07225816 · lead sponsor · 2025-11-07
RECRUITINGA Research Study on the Effects of NNC0537-1482 in Participants With Heart FailureNCT07218627 · lead sponsor · 2025-10-23
RECRUITINGCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) AmyloidosisNCT07207811 · lead sponsor · 2025-10-02
RECRUITINGA Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 DiabetesNCT07112339 · lead sponsor · 2025-08-15
RECRUITINGSafety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108NCT07153172 · lead sponsor · 2025-08-06
RECRUITINGA Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular HypertrophyNCT06979375 · lead sponsor · 2025-06-30
RECRUITINGA Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular HypertrophyNCT06979362 · lead sponsor · 2025-06-27
RECRUITINGThe Role of the Amylin Analogue Cagrilintide in Bone MetabolismNCT07010432 · lead sponsor · 2025-06-12
RECRUITINGGeneral Use-results Surveillance With Awiqli in Patients With Diabetes MellitusNCT06807190 · lead sponsor · 2025-04-15
RECRUITINGA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseNCT06717698 · lead sponsor · 2024-12-02
RECRUITINGRegulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in KoreaNCT05714683 · lead sponsor · 2027-01-31
NOT_YET_RECRUITINGAMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose WeightNCT07668401 · lead sponsor · 2027-01-07
NOT_YET_RECRUITINGA Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityNCT07861100 · lead sponsor · 2026-10-26
NOT_YET_RECRUITINGA Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide MedicationNCT07855133 · lead sponsor · 2026-09-30
NOT_YET_RECRUITINGA Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body WeightNCT07845578 · lead sponsor · 2026-09-25
NOT_YET_RECRUITINGReal-World Patient and Physician Experience With Semaglutide Across Six Emerging MarketsNCT07850765 · lead sponsor · 2026-08-28
COMPLETEDA Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 DiabetesNCT07357740 · lead sponsor · 2026-08-27
WITHDRAWNA Retrospective Real-World Cohort StudyNCT07781371 · lead sponsor · 2026-08-20
ACTIVE_NOT_RECRUITINGResearch Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin IcodecNCT07658417 · lead sponsor · 2026-07-02
ENROLLING_BY_INVITATIONA Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body WeightNCT07357766 · lead sponsor · 2026-06-22
WITHDRAWNSponsor roles
lead sponsor1,068
collaborator206
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.